O slideshow foi denunciado.
Utilizamos seu perfil e dados de atividades no LinkedIn para personalizar e exibir anúncios mais relevantes. Altere suas preferências de anúncios quando desejar.
Forecast
Bone Cancer Drugs Market Analysis
12%
Accelerating
The growth momentum of the bone cancer
drugs market is expected to accelerate in the
second half of the f...
Geographic segmentation
47%
Know Other Regions
High sale of approved drugs
and chemotherapy drugs is
propelling market gro...
Osteosarcoma
Others
Segmentation by
39%
61%
Osteosarcoma
has a high risk of
spreading to
other parts of the
body
Find Out ...
Drivers
Rising prevalence of osteosarcoma in younger patients.
Trends
Emergence of targeted therapies for the treatment of...
Vendors
Bristol-Myers Squibb Company
Bayer AG
Amgen Merck & Co. Inc.
Pfizer Inc.
See all vendors
What
People
say
Technavio’s report had good market coverage
and an exhaustive understanding of market
trends, drivers, and...
Would you like to
know more on the
report ?
YES, please
NO, I would rather see other
reports
Some about Technavio
10,000+
8000+
500+
50+
www.technavio.com
Visit us here:
North America
Chicago, USA
Europe
London, UK
...
Próximos SlideShares
Carregando em…5
×

Bone Cancer Drugs Market Analysis

18 visualizações

Publicada em

This industry research report provides a detailed analysis of the market based on indication (osteosarcoma, Ewing’s sarcoma, chondrosarcoma, and others) and geography (Asia, Europe, North America, and ROW). The report analyzes the market’s competitive landscape and offers information on several bone cancer drugs manufacturers including Amgen, Bayer AG, Bristol-Myers Squibb Company, Merck & Co. Inc., and Pfizer Inc.

Publicada em: Negócios
  • Seja o primeiro a comentar

Bone Cancer Drugs Market Analysis

  1. 1. Forecast Bone Cancer Drugs Market Analysis
  2. 2. 12% Accelerating The growth momentum of the bone cancer drugs market is expected to accelerate in the second half of the forecast period when compared to the increase in the first half. The global bone cancer drugs market will witness incremental growth over the next five years. Know More 2019 2020 2021 2022 2023 Year-over-year growth
  3. 3. Geographic segmentation 47% Know Other Regions High sale of approved drugs and chemotherapy drugs is propelling market growth in the region.
  4. 4. Osteosarcoma Others Segmentation by 39% 61% Osteosarcoma has a high risk of spreading to other parts of the body Find Out More
  5. 5. Drivers Rising prevalence of osteosarcoma in younger patients. Trends Emergence of targeted therapies for the treatment of bone cancer. Challenges High cost of treatment + Our report can offer you critical insights Get More Insights
  6. 6. Vendors Bristol-Myers Squibb Company Bayer AG Amgen Merck & Co. Inc. Pfizer Inc. See all vendors
  7. 7. What People say Technavio’s report had good market coverage and an exhaustive understanding of market trends, drivers, and challenges. The report was excellent in terms of geographical segmentation. 10/10 on value for money.The market coverage, segmentation, and vendor landscape were of excellent standards. In addition, the customer support team is super responsive. A leading life sciences company A renowned solutions company One of the top-rated global airlines Let us help you gain better market insights! Explore the platform
  8. 8. Would you like to know more on the report ? YES, please NO, I would rather see other reports
  9. 9. Some about Technavio 10,000+ 8000+ 500+ 50+ www.technavio.com Visit us here: North America Chicago, USA Europe London, UK Asia Bangalore, India Reports Cover: Market Scenarios, Vendor landscape & Industry Road Maps. Option to customize report & access to analysts on every report purchase

×